(Q41550507)

3 October 2017

title

Structure-function relationships of alkyl-lysophospholipid analogs in selective antitumor activity (English)

1 reference

3 October 2017

W R Vogler

1

1 reference

3 October 2017

A C Olson

2

1 reference

3 October 2017

J Hajdu

3

1 reference

3 October 2017

M Shoji

4

1 reference

3 October 2017

R Raynor

5

1 reference

3 October 2017

J F Kuo

6

1 reference

3 October 2017

publication date

1 June 1993

1 reference

3 October 2017

1 reference

3 October 2017

volume

28

1 reference

3 October 2017

issue

6

1 reference

3 October 2017

page(s)

511-516

1 reference

Lack of correlation between cytotoxicity of agonists and antagonists of platelet activating factor [paf-acether] in neoplastic cells and modulation of [3H]-paf-acether binding to platelets from humans in vitro.

3 October 2017

cites work

1 reference

12 December 2020

Effects of phorbol ester on translocation and down-regulation of protein kinase C and phosphorylation of endogenous proteins in human acute myeloid leukemia cell line KG-1 and its phorbol ester-resistant subline KG-1a.

1 reference

12 December 2020

Purging murine leukemic marrow with alkyl-lysophospholipids

1 reference

12 December 2020

Calcium-dependent protein kinase: widespread occurrence in various tissues and phyla of the animal kingdom and comparison of effects of phospholipid, calmodulin, and trifluoperazine

1 reference

12 December 2020

New assay for the O-alkyl cleavage enzyme with alkyl-lysophospholipids as substrates

1 reference

12 December 2020

Inhibition of Na,K-ATPase and sodium pump by anticancer ether lipids and protein kinase C inhibitors ET-18-OCH3 and BM 41.440.

1 reference

12 December 2020

Antileukemic effect of alkyl phospholipids. II. Prolongation of survival times of leukemic mice by alkyl ethyleneglycophospholipids

1 reference

12 December 2020

Antineoplastic activity of the thioether lysophospholipid derivative BM 41.440 in vitro.

1 reference

12 December 2020

Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts

1 reference

12 December 2020

Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity.

1 reference

12 December 2020

Modulation of chemical carcinogenesis in rats by alkyl lysophospholipids

1 reference

12 December 2020

The biocleavage of alkyl glyceryl ethers in Morris hepatomas and other transplantable neoplasms.

1 reference

12 December 2020

Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines.

1 reference

12 December 2020

Effect of alkyl-lysophospholipids on phosphatidylcholine biosynthesis in leukemic cell lines.

1 reference

12 December 2020

Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome

1 reference

12 December 2020

A NEW PTERIDINE-REQUIRING ENZYME SYSTEM FOR THE OXIDATION OF GLYCERYL ETHERS

1 reference

12 December 2020

Ether lipids and analogs in experimental cancer therapy. A brief review of the Munich experience

1 reference

12 December 2020

Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine

1 reference

12 December 2020

Molecular dynamics of antitumor ether-linked phospholipids in model membranes: a spin-label study

1 reference

12 December 2020

Tetrahydropteridine-dependent cleavage enzyme for O-alkyl lipids: substrate specificity

1 reference

12 December 2020

Synthesis and antitumor activity of new alkylphospholipids containing modifications of the phosphocholine moiety

1 reference

12 December 2020

A novel nontoxic alkyl-phospholipid with selective antitumor activity, plasmanyl-(N-acyl)-ethanolamine (PNAE), isolated from degenerating chick embryonal tissues and from an anticancer biopreparation cACPL.

1 reference

12 December 2020

Purging leukemic cells from simulated human remission marrow with alkyl-lysophospholipid

1 reference

12 December 2020

The effect of alkyl-lysophospholipids on tritiated thymidine incorporation and clonogenicity in vitro of normal and leukemic human cells

1 reference

12 December 2020

Inhibition of protein kinase C, (sodium plus potassium)-activated adenosine triphosphatase, and sodium pump by synthetic phospholipid analogues

1 reference

12 December 2020

Structural features of platelet activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) required for hypotensive and platelet serotonin responses

1 reference

12 December 2020

Disturbance of phospholipid metabolism during the selective destruction of tumor cells induced by alkyl-lysophospholipids

1 reference

12 December 2020

Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture

1 reference

12 December 2020

Phospholipid-sensitive Ca2+-dependent protein phosphorylation system in various types of leukemic cells from human patients and in human leukemic cell lines HL60 and K562, and its inhibition by alkyl-lysophospholipid

1 reference

12 December 2020

Selective destruction of human leukemic cells by alkyl-lysophospholipids

1 reference

12 December 2020

Granuloerythropoietic colonies in human bone marrow, peripheral blood, and cord blood

1 reference

12 December 2020

Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02536082

1 reference

release_rotas4aojfdczjoburjpy5ooua

3 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rotas4aojfdczjoburjpy5ooua

24 November 2022

mapped directly with Wikidata item

1 reference